Yu-qi Yao

ORCID: 0000-0002-9443-1316
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • HER2/EGFR in Cancer Research
  • Big Data and Business Intelligence
  • Vascular Tumors and Angiosarcomas
  • Lung Cancer Research Studies
  • Lymphoma Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Cancer Mechanisms and Therapy
  • Neuroendocrine Tumor Research Advances

Sichuan Cancer Hospital
2021-2022

University of Electronic Science and Technology of China
2022

Cancer Hospital and Research Institute
2021

It is well established that estrogen receptor (ER), progesterone (PR), and human epidermal growth factor (HER2) could be regarded as prognostic factors in breast cancer. Ultrasound-guided fine needle aspiration cytology (FNAC) has revolutionized the management of cancers, providing less invasive quick diagnostic method. There are hardly any studies on correlation between cytomorphology biomarkers. We retrospectively analyzed immunohistochemistry fluorescence situ hybridization cancer...

10.1155/2022/6302751 article EN cc-by Analytical Cellular Pathology 2022-03-14

Abstract Purpose It is well established that estrogen receptor (ER), progesterone (PR) and human epidermal growth factor (HER2) have therapeutic implications cand could be regarded as prognostic factors in breast cancer. Ultrasound-guided fine needle aspiration cytology (FNAC) has revolutionized the management of cancers, providing less invasive quick diagnostic method. There are hardly studies on correlation between cytomorphology three markers. Methods We retrospectively analyzed...

10.21203/rs.3.rs-265497/v1 preprint EN cc-by Research Square (Research Square) 2021-02-26
Coming Soon ...